1. Comparative Analysis of Inhibitor Binding to Peroxiredoxins from Candidatus Liberibacter asiaticus and Its Host Citrus sinensis.
- Author
-
Gupta DN, Lonare S, Rani R, Singh A, Ghosh DK, Tomar S, and Sharma AK
- Subjects
- Protein Binding, Enzyme Inhibitors pharmacology, Enzyme Inhibitors chemistry, Rhizobiaceae, Bacterial Proteins metabolism, Bacterial Proteins antagonists & inhibitors, Bacterial Proteins chemistry, Triterpenes pharmacology, Triterpenes chemistry, Triterpenes metabolism, Liberibacter metabolism, Surface Plasmon Resonance, Molecular Docking Simulation, Peroxiredoxins antagonists & inhibitors, Peroxiredoxins metabolism, Peroxiredoxins chemistry, Pentacyclic Triterpenes pharmacology, Pentacyclic Triterpenes chemistry, Citrus sinensis microbiology, Citrus sinensis chemistry
- Abstract
The peroxiredoxins (Prxs), potential drug targets, constitute an important class of antioxidant enzymes present in both pathogen and their host. The comparative binding potential of inhibitors to Prxs from pathogen and host could be an important step in drug development against pathogens. Huanglongbing (HLB) is a most devastating disease of citrus caused by Candidatus Liberibacter asiaticus (CLa). In this study, the binding of conoidin-A (conoidin) and celastrol inhibitor molecules to peroxiredoxin of bacterioferritin comigratory protein family from CLa (CLaBCP) and its host plant peroxiredoxin from Citrus sinensis (CsPrx) was assessed. The CLaBCP has a lower specific activity than CsPrx and is efficiently inhibited by conoidin and celastrol molecules. The biophysical studies showed conformational changes and significant thermal stability of CLaBCP in the presence of inhibitor molecules as compared to CsPrx. The surface plasmon resonance (SPR) studies revealed that the conoidin and celastrol inhibitor molecules have a strong binding affinity (K
D ) with CLaBCP at 33.0 µM, and 18.5 µM as compared to CsPrx at 52.0 µM and 61.6 µM, respectively. The docked complexes of inhibitor molecules showed more structural stability of CLaBCP as compared to CsPrx during the run of molecular dynamics-based simulations for 100 ns. The present study suggests that the conoidin and celastrol molecules can be exploited as potential inhibitor molecules against the CLa to manage the HLB disease., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2024
- Full Text
- View/download PDF